Titan Pharmaceuticals Inc. | Key People and Executives
Marc Rubin
Executive Chairman
Sunil Bhonsle
President, Chief Executive Officer, CFO & Director
Federico Seghi Recli
Lead Director
Rajinder Kumar
Independent Director
Scott Andrew Smith
Independent Director
Joseph A. Akers
Independent Director
James R. McNab
Independent Director
M. David MacFarlane
Independent Director
Marc Rubin
Executive Chairman
Sunil Bhonsle
President, Chief Executive Officer, CFO & Director
Katherine L. Beebe-DeVarney
Chief Scientific Officer & Executive VP
Brian Crowley
Vice President-Finance
Katherine L. Glassman-Beebe
Chief Development Officer & Executive VP
Federico Seghi Recli
Lead Director
Stephen Kilmer
Investor Relations Contact
Susan Ajay Thomas
Head-Media Relations
Rajinder Kumar
Independent Director
Scott Andrew Smith
Independent Director
Joseph A. Akers
Independent Director
James R. McNab
Independent Director
M. David MacFarlane
Independent Director
| Address |
400 Oyster Point Boulevard
South San Francisco California 94080
United States
|
|
Employees
|
- |
| Website |
http://www.titanpharm.com |
| Updated |
07/08/2019 |
| Titan Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing proprietary therapeutics primarily for the treatment of medical disorders. Its products include Probuphine, provides non fluctuating blood levels of buprenorphine; Ropinirole implant, which provides dopaminergic stimulation; and T3 implant, which is used in hypothyroidism treatment. Its products are subdermal implants, which utilizes ProNeura drug delivery platform. |
